Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $465.00 price target on DexCom (NASDAQ: DXCM) after the analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE